Federal Register · Regulatory notice
United States of America, et al. v. RealPage, Inc., et al.; Response of the United States to Public Comments
A Notice notice explicitly mentions the company. Read the cited text for its role.
Follow MS- Became public
- Nov 9, 2026
- Event / period date
- Not stated
- Collected
- Nov 10, 2026, 10:46 AM EST
Why this is connected
The source explicitly mentions MORGAN STANLEY. A mention alone does not establish a financial benefit.
Source evidence
Read the source excerpt or record
he full relief that [the] United States sought in its complaint.'' Hewlett Packard Enter., 2026 WL 2349970, at *17. The United States' predictions about the efficacy of the remedy are to be afforded deference by the Court. See, e.g., Microsoft, 56 F.3d at 1461 (recognizing courts should give ``due respect to the Justice Department's . . . view of the nature of its case''); United States v. Iron Mountain, Inc., 217 F. Supp. 3d 146, 152-53 (D.D.C. 2016) (``In evaluating objections to settlement agreements under the Tunney Act, a court must be mindful that [t]he government need not prove that the settlements will perfectly remedy the alleged antitrust harms[;] it need only provide a factual basis for concluding that the settlements are reasonably adequate remedies for the alleged harms.'') (internal citations omitted); United States v. Republic Servs., Inc., 723 F. Supp. 2d 157, 160 (D.D.C. 2010) (noting ``the deferential review to which the government's proposed remedy is accorded''); United States v. Archer-Daniels-Midland Co., 272 F. Supp. 2d 1, 6 (D.D.C. 2003) (``A district court must accord due respect to the government's prediction as to the effect of proposed remedies, its perception of the market structure, and its view of the nature of the case''). In determining whether a proposed settlement is in the public interest, a district court ``is not permitted to reject the pro
Congressional trading in MS
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Oct 7, 2026 · disclosed Nov 5, 2026 · Spouse
Traded 7 days before earnings - Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Oct 2, 2026 · disclosed Nov 5, 2026 · Dependent
Traded 12 days before earnings - Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
- Jul 17, 2026$1K–$15K
Rep. Dan Newhouse (R-WA-4)
$1K–$15K · Traded Jul 10, 2026 · disclosed Jul 17, 2026 · Spouse
Traded 5 days before earnings - Jan 15, 2026$1K–$15K
Rep. Julie Johnson (D-TX-32)
$1K–$15K · Traded Dec 18, 2025 · disclosed Jan 15, 2026 · Joint
- Jan 14, 2026$50K–$100K
Rep. Steve Cohen (D-TN-9)
Sold (partial) Morgan Stanley MS
$50K–$100K · Traded Dec 17, 2025 · disclosed Jan 14, 2026
- Dec 15, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Nov 18, 2025 · disclosed Dec 15, 2025
- Dec 11, 2025$1K–$15K
Rep. Julie Johnson (D-TX-32)
Sold (partial) Morgan Stanley MS
$1K–$15K · Traded Nov 13, 2025 · disclosed Dec 11, 2025 · Joint
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.